TNF- α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study
ConclusionsA direct and positive correlation between the use of TNF- α blockers and a reduction in the incidence of COVID-19 could suggest the prophylactic role of these drugs in preventing COVID-19 in patients with RA and SpA.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Arthritis | COVID-19 | Enbrel | Humira | Pandemics | Remicade | Rheumatoid Arthritis | Rheumatology | SARS | Statistics | Study